Just-Evotec Biologics
Evotec is a life science company pioneering the future of drug discovery and preclinical development. They aim for technology and science leadership, accelerating the journey from concept to cure through cutting-edge technology, disruptive science, and extensive disease knowledge. Their expertise spans from small molecules to biotherapeutics, with a focus on scientific excellence, deep disease understanding, and proprietary next-gen technology platforms. Through Just – Evotec Biologics, they have revolutionized biologics design, development, and manufacturing, making high-quality therapies more accessible and affordable. Their fully integrated R&D value chain and flexible partnering models deliver speed, efficiency, and quality to ensure better treatments reach patients sooner.
Industries
Nr. of Employees
Very Large (1000+)
Just-Evotec Biologics
Hamburg, Hamburg, Germany, Europe
Products
Pan-omics data platform / molecular patient databases
Platforms and curated molecular patient datasets for multi-omics analysis and translational research.
iPSC discovery / cell therapy platform
iPSC-derived cellular platforms for disease modelling, screening and development of cell therapies.
Resource hub of scientific content (Science Pool)
Curated technical resources, posters, webinars and method descriptions supporting scientific reproducibility and knowledge transfer.
Pan-omics data platform / molecular patient databases
Platforms and curated molecular patient datasets for multi-omics analysis and translational research.
iPSC discovery / cell therapy platform
iPSC-derived cellular platforms for disease modelling, screening and development of cell therapies.
Resource hub of scientific content (Science Pool)
Curated technical resources, posters, webinars and method descriptions supporting scientific reproducibility and knowledge transfer.
Services
Discovery & Preclinical Development (CRO services)
Integrated target ID, hit discovery, lead optimisation and preclinical development offered as CRO services.
Biologics development and GMP manufacturing services
Process development, cell line development, and clinical- to commercial-stage GMP manufacturing for biotherapeutics.
ADME-Tox and safety testing services
In vitro ADME and toxicology testing to support candidate selection and preclinical safety evaluation.
mAb optimisation and cell line development services
Monoclonal antibody optimisation and establishment of production cell lines to support biologics pipelines.
Pan-omics and molecular patient database services
Multi-omics data integration and curated molecular patient databases to support translational research and target validation.
iPSC discovery and cell therapy development
iPSC-based disease modelling, screening and cell therapy development services.
Discovery & Preclinical Development (CRO services)
Integrated target ID, hit discovery, lead optimisation and preclinical development offered as CRO services.
Biologics development and GMP manufacturing services
Process development, cell line development, and clinical- to commercial-stage GMP manufacturing for biotherapeutics.
ADME-Tox and safety testing services
In vitro ADME and toxicology testing to support candidate selection and preclinical safety evaluation.
mAb optimisation and cell line development services
Monoclonal antibody optimisation and establishment of production cell lines to support biologics pipelines.
Pan-omics and molecular patient database services
Multi-omics data integration and curated molecular patient databases to support translational research and target validation.
iPSC discovery and cell therapy development
iPSC-based disease modelling, screening and cell therapy development services.
Expertise Areas
- Drug discovery and preclinical development
- Biologics development and GMP manufacturing
- ADME-Tox and safety assessment
- Pan-omics integration and biomarker discovery
Key Technologies
- Induced pluripotent stem cells (iPSC)
- CRISPR-based genetic screening
- Proteomics
- Metabolomics